Recent news on Travoprost

Comparing Bimatoprost Daily versus Every Two Days in Patients With ...  -  May 15, 2007
DG NewsThese results are not unlike what has been seen with other prostaglandin analogs -- travoprost and latanoprost -- both of which show a statistically

Glaucoma Experts Determine That Reducing Intraocular Pressure ...  -  May 11, 2007
Medical News Today (press release),A retrospective analysis of the Xalatan Lumigan Travatan (XLT) study show that three prostaglandins, latanoprost, bimatoprost and travoprost reduce the

Alcon global sales up 16.1% in fourth quarter 2006  -  Feb 12, 2007
OSN SuperSite (subscription),Pharmaceutical sales grew 20.4% to $475.9 million, led by sharp increases in sales of the glaucoma medications Travatan (travoprost), Azopt (brinzolamide)

Mergers, Acquisitions, etc.  -  Feb 16, 2007
OSN SuperSite (subscription),Akorn officials expect the drugs — generic equivalents versions of latanoprost, bimatoprost and travoprost — to be manufactured by South Korea-based Taejoon

Akorn, Azad Partner on 3 Glaucoma Drugs  -  Jan 9, 2007
Forbes,The three ophthalmic ANDA drugs, Latanoprost, Bimatoprost and Travoprost, are expected to be manufactured by Taejoon Pharmaceutical Co.

Akorn and Azad Ink Gluacoma Deal  -  Jan 9, 2007
Genetic Engineering News (press release),The companies report that the products, Latanoprost, Bimatoprost, and Travoprost, have a total US market-size of $870 million, according to 2006 IMS data.

Market Report -- In Play (AKN)  -  Jan 9, 2007
MSN Money...with Azad Pharma to develop and supply Latanoprost, Bimatoprost and Travoprost, three ophthalmic ANDA drug products for the treatment of glaucoma.

Cheaper drugs good news for patients  -  Dec 2, 2006
Sydney Morning Herald,...diabetes patients will get rosiglitazone with metformin (Avandamet); and 10000 glaucoma patients will receive travoprost with timolo maleate (Duotrav).

FDA Approvals: Risperdal/Risperdal M-TAB, Travatan Z, Rituxan  Oct 24, 2006
...the treatment of irritability associated with autistic disorder in pediatric patients aged 5 to 16 years, and a new formulation of travoprost 0.004% ophthalmic ... -Medscape (subscription) Look Out!  Oct 24, 2006
The free confidential programme is available for glaucoma patients taking travoprost, patients join for free when they visit a glaucoma clinic. ... -50 Connect, Alcon's TRAVATAN(R) Z Solution Approved by FDA for Treatment of ...  Sep 22, 2006
Announced today that the US Food and Drug Administration (FDA) has approved TRAVATAN(R) Z (travoprost ophthalmic solution) 0.004% for the reduction of elevated ... -PipelineReview.com

Alcon's TRAVATAN(R) Z Solution Approved by FDA for Treatment of ...  Sep 21, 2006
21, 2006--Alcon, Inc. (NYSE:ACL) announced today that the US Food and Drug Administration (FDA) has approved TRAVATAN(R) Z (travoprost ophthalmic solution ... -Business Wire

Alcon Granted FDA Approval For Travatan Solution For Treatment Of ...  Sep 21, 2006
The company added that travoprost ophthalmic solution or TRAVATAN Z reduces the elevated intraocular pressure in patients with open-angle glaucoma or ocular ... -Trading Markets

Cheaper drugs good news for patients  -  Dec 2, 2006
Sydney Morning Herald,...diabetes patients will get rosiglitazone with metformin (Avandamet); and 10000 glaucoma patients will receive travoprost with timolo maleate (Duotrav).



Brinzolamide 1% Found More Effective Than Brimonidine 0.15% When ...  May 1, 2006
...efficacy of twice daily brimonidine 0.15% purite versus twice daily brinzolamide 1% ophthalmic suspension as additional therapy to travoprost 0.004% in eyes of ... - DG News

NEW STUDY DEMONSTRATES A SINGLE COMPOUND AS EFFECTIVE AS A FIXED ...  May 3, 2006
A comparison of latanoprost, bimatoprost and travoprost in patients with elevated intraocular pressure a 12-week randomised, masked-elevator, multicentre study ... - ITNews

(BW) Alcon's First Quarter Sales Rise 8.1 Percent, Net Earnings ...  Apr 24, 2006
DuoTrav(TM), a fixed combination of travoprost 0.004% and timolol 0.5%, received a positive recommendation for approval in the European Union by the ... - Houston Chronicle

Alcon Q1 Net Earnings Rise 18.5% Primarily On Healthy Sales Growth ...  Apr 24, 2006
DuoTrav, a fixed combination of travoprost 0.004% and timolol 0.5%, received a positive recommendation for approval in the European Union by the Committee for ... - Trading Markets





CMPH - Initial Marketing Authorisation Applications,Europe ...  Feb 24, 2006
...-- Duotrav (travoprost/timolol maleate), Alcon Laboratories. Duotrav is an eye-drops solution, intended for the decrease of intraocular ... - Medical News Today,

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional